Hepatic tumor microvasculature and adjacent tumor cells

The hepatic tumor microvasculature and adjacent tumor cells represent a specialized physiological target site primarily associated with hepatocellular carcinoma (HCC) and hypervascular liver metastases. Unlike healthy liver parenchyma, which receives approximately 75% of its blood supply from the portal vein, hepatic tumors are almost exclusively supplied by the hepatic artery (StatPearls, 2023). This unique hemodynamic profile allows for the selective delivery of therapeutic agents directly into the tumor's vascular bed via intra-arterial catheterization (NIH, 2022). The microvasculature in this region is characterized by structural abnormalities, including high permeability and a lack of functional lymphatic drainage, a phenomenon known as the Enhanced Permeability and Retention (EPR) effect (PubMed, PMID: 3546466). This effect facilitates the selective accumulation and prolonged retention of agents like ethiodized oil (Lipiodol) and drug-eluting beads within the tumor and its immediate surroundings (FDA, 2014). Targeting this compartment is the fundamental principle behind locoregional therapies such as transarterial chemoembolization (TACE) and selective internal radiation therapy (SIRT), which aim to induce tumor necrosis through ischemia and localized high-dose therapy while sparing the surrounding healthy liver tissue.

Other names

Hepatic tumor microenvironmentHCC microvasculatureTumor-associated hepatic vesselsLiver tumor interstitial space

Selective accumulation via the hepatic artery and the Enhanced Permeability and Retention (EPR) effect, followed by mechanical embolization or localized delivery of cytotoxic/radioactive agents.